Princeton Docket #
11-2691-1
Using
various in vitro and in vivo xenograft model systems and
clinical samples, researchers in the department of molecular biology, Princeton University
have validated a stage-specific functional role of the miR-200 family to tumor
progression. Current studies
suggest that the miR-200 family may hinder an early step...
Published: 3/30/2022
|
Inventor(s): Yibin Kang, Manav Korpal
Keywords(s): biomarker/diagnostic, cancer/oncology, drug target
Category(s): Medical Devices/Diagnostics, Biotechnology/Pharmaceuticals
|